Clinical trial facilitator Mural Health Technologies raised $8 million in seed funding, co-CEO Sam Whitaker tells Axios exclusively.
Why it matters:Ninety-seven percent of U.S. patients and providers never participate in a clinical trial, with most research located at prestigious, difficult-to-access academic medical centers.
